Full title
Hip and femoral fracture anticoagulation surgical timing evaluation
Background
There has been a focus on improving the care of patients sustaining hip fractures, concentrating on rapid assessment, optimisation for surgery, early surgery, and rehabilitation. This has led to significant improvements in outcome for this patient group as a whole.
However a large number of these patients have not experienced the same degree of benefit, namely those who take anticoagulant medications (e.g., warfarin). Hip fracture surgery is usually delayed for these patients.
Evaluating the current national peri-operative management of anticoagulated hip fracture patients is important to determine scope for improvement and whether further work on this topic is required.
What we did
The HASTE Study was a multi-centre prospective service evaluation that evaluated the epidemiology and management of hip and femoral fracture patients on oral anticoagulant medications.
Data on anticoagulated and non-anticoagulated hip and femoral fracture patients was collected prospectively by collaborators at participating units over three months.
Project lead
Mr Will Eardley
Trainee lead
Mr Muhamed Alanie
Funder
AO UK and I
Sponsor
South Tees Hospitals NHS Foundation Trust in collaboration with CORNET
Current status
Closed
Publications
The Impact of Anticoagulant Medications on Fragility Femur Fracture Care: The Hip and Femoral Fracture Anticoagulation Surgical Timing Evaluation (Haste) Study
Farhan-Alanie, et al. (2024)
Injury
Dedicated anticoagulation management protocols in fragility femoral fracture care – a source of significant variance and limited effectiveness in improving time to surgery: The hip and femoral fracture anticoagulation surgical timing evaluation (HASTE) study
Farhan-Alanie, et al. (2024)
Injury